{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:09:23Z","timestamp":1778872163088,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71974040"],"award-info":[{"award-number":["71974040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302510\uff0c81273185"],"award-info":[{"award-number":["81302510\uff0c81273185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The purpose of this study was to develop and validate the prostate cancer scale among the system of quality-of-life instruments for patients with cancer (QLICP-PR V2.0) to provide a reliable tool for assessing quality of life changes and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      Application of programmed decision procedures, including multiple qualitative and quantitative analyses with general module and specific module combination pattern, were utilized to develop the QLICP-PR V2.0. On the basis of the data from 115 admitted and discharged patients with prostate cancer, the reliability, validity, and responsiveness of the QLICP-PR V2.0 scale were evaluated using correlation analysis, multi-trait scaling analysis, factor analysis, structural equation model, and paired\n                      <jats:italic>t<\/jats:italic>\n                      -tests, as well as combined with generalizability theory.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cronbach\u2019s alpha, test\u2013retest reliability, and intra-class correlation coefficient of the total scale were 0.886, 0.896, and 0.889, respectively. Correlation analysis and factor analysis confirmed good construct validity and criterion-related validity. The score differences at all five domains and the total scale before and after the treatment were statistically significant (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05), with the SRM value ranging from \u2212\u20091.152 to \u2212\u20090.408, and the total scale was \u2212\u20091.152. Generalizability theory results showed that the generalization coefficient of the five domains of the scale range from 0.575 to 0.764, and the reliability index between 0.529 and 0.748.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The QLICP-PR V2.0 has good psychometric properties in reliability, validity, and responsiveness, and can be used to evaluate the quality of life of patients with prostate cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-19044-4","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T13:50:20Z","timestamp":1768225820000},"page":"5854-5864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Longitudinal Study on Development and Validation of the Prostate Cancer Scale Among the System of Quality of Life Instruments for Patients with Cancer (QLICP-PR V2.0) Based on Classical Test Theory and Generalizability Theory"],"prefix":"10.1245","volume":"33","author":[{"given":"Wenxing","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengbo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianci","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonghua","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"6","key":"19044_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"19044_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"19044_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al. 2022 Update on prostate cancer epidemiology and risk factors\u2014a systematic review. Eur Urol. 2023;84(2):191\u2013206. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021.","journal-title":"Eur Urol."},{"issue":"1","key":"19044_CR4","doi-asserted-by":"publisher","first-page":"26338","DOI":"10.1038\/s41598-024-77863-z","volume":"14","author":"J Chen","year":"2024","unstructured":"Chen J, He L, Ni Y, et al. Prevalence and associated risk factors of prostate cancer among a large Chinese population. Sci Rep. 2024;14(1):26338. https:\/\/doi.org\/10.1038\/s41598-024-77863-z.","journal-title":"Sci Rep."},{"issue":"3","key":"19044_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"19044_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, et al. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77(1):38\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.005.","journal-title":"Eur Urol."},{"issue":"1","key":"19044_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE, et al. Prostate cancer. Nat Rev Dis Primers. 2021;7(1):9. https:\/\/doi.org\/10.1038\/s41572-020-00243-0.","journal-title":"Nat Rev Dis Primers."},{"issue":"6","key":"19044_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877\u201392. https:\/\/doi.org\/10.1016\/j.euo.2021.09.006.","journal-title":"Eur Urol Oncol."},{"issue":"1","key":"19044_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin."},{"issue":"16","key":"19044_CR10","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","volume":"44","author":"G Van Andel","year":"2008","unstructured":"Van Andel G, Bottomley A, Foss\u00e5 SD, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44(16):2418\u201324. https:\/\/doi.org\/10.1016\/j.ejca.2008.07.030.","journal-title":"Eur J Cancer."},{"issue":"6","key":"19044_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0090-4295(97)00459-7","volume":"50","author":"P Esper","year":"1997","unstructured":"Esper P, Mo F, Chodak G, et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50(6):920\u20138. https:\/\/doi.org\/10.1016\/S0090-4295(97)00459-7.","journal-title":"Urology."},{"issue":"4","key":"19044_CR12","first-page":"447","volume":"56","author":"JE Batista-Miranda","year":"2003","unstructured":"Batista-Miranda JE, Sevilla-Cecilia C, Torrubia R, et al. Quality of life in prostate cancer patients and controls: psychometric validation of the FACTP-4 in Spanish, and relation to urinary symptoms. Arch Esp Urol. 2003;56(4):447\u201354.","journal-title":"Arch Esp Urol."},{"issue":"7","key":"19044_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1097\/00005650-199807000-00007","volume":"36","author":"MS Litwin","year":"1998","unstructured":"Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36(7):1002\u201312. https:\/\/doi.org\/10.1097\/00005650-199807000-00007.","journal-title":"Med Care."},{"issue":"6","key":"19044_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/s0090-4295(00)00858-x","volume":"56","author":"JT Wei","year":"2000","unstructured":"Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899\u2013905. https:\/\/doi.org\/10.1016\/s0090-4295(00)00858-x.","journal-title":"Urology."},{"key":"19044_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1477-7525-10-96","volume":"10","author":"YJ Chang","year":"2012","unstructured":"Chang YJ, Liang WM, Wu HC, et al. Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients. Health Qual Life Outcomes. 2012;10:96. https:\/\/doi.org\/10.1186\/1477-7525-10-96.","journal-title":"Health Qual Life Outcomes."},{"issue":"2","key":"19044_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3346\/jkms.2006.21.2.295","volume":"21","author":"JH Hong","year":"2006","unstructured":"Hong JH, Jeon SS, Lee HM, et al. The functional assessment of cancer therapy-prostate (FACT-P) scales in men with prostate cancer: reliability and validity of the Korean version. J Korean Med Sci. 2006;21(2):295\u20139. https:\/\/doi.org\/10.3346\/jkms.2006.21.2.295.","journal-title":"J Korean Med Sci."},{"issue":"5","key":"19044_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2217\/cer.14.41","volume":"3","author":"D Chu","year":"2014","unstructured":"Chu D, Popovic M, Chow E, et al. Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. J Comp Eff Res. 2014;3(5):523\u201331. https:\/\/doi.org\/10.2217\/cer.14.41.","journal-title":"J Comp Eff Res."},{"issue":"6","key":"19044_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.urology.2009.04.070","volume":"75","author":"J Bergman","year":"2010","unstructured":"Bergman J, Saigal CS, Kwan L, et al. Responsiveness of the University of California-Los Angeles prostate cancer index. Urology. 2010;75(6):1418\u201323. https:\/\/doi.org\/10.1016\/j.urology.2009.04.070.","journal-title":"Urology."},{"issue":"1","key":"19044_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12955-016-0571-y","volume":"14","author":"A Anota","year":"2016","unstructured":"Anota A, Mariet AS, Maingon P, et al. Cross-cultural adaptation and validation of the French version of the expanded prostate cancer index composite questionnaire for health-related quality of life in prostate cancer patients. Health Qual Life Outcomes. 2016;14(1):168. https:\/\/doi.org\/10.1186\/s12955-016-0571-y.","journal-title":"Health Qual Life Outcomes."},{"issue":"1","key":"19044_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12955-019-1197-7","volume":"17","author":"RG Mancha","year":"2019","unstructured":"Mancha RG, Mu\u00f1oz M, de la Cruz-Merino L, et al. Development and validation of a sexual relations satisfaction scale in patients with breast cancer\u2014\"SEXSAT-Q\". Health Qual Life Outcomes. 2019;17(1):143. https:\/\/doi.org\/10.1186\/s12955-019-1197-7.","journal-title":"Health Qual Life Outcomes."},{"issue":"1","key":"19044_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/ijc.23036","volume":"122","author":"C Wan","year":"2008","unstructured":"Wan C, Yang Z, Meng Q, et al. Development and validation of the general module of the system of quality of life instruments for cancer patients. Int J Cancer. 2008;122(1):190\u20136. https:\/\/doi.org\/10.1002\/ijc.23036.","journal-title":"Int J Cancer."},{"key":"19044_CR22","doi-asserted-by":"publisher","first-page":"915103","DOI":"10.3389\/fonc.2022.915103","volume":"12","author":"F Li","year":"2022","unstructured":"Li F, Zhou J, Wan C, et al. Development and validation of the breast cancer scale QLICP-BR V2.0 based on classical test theory and generalizability theory. Front Oncol. 2022;12:915103. https:\/\/doi.org\/10.3389\/fonc.2022.915103.","journal-title":"Front Oncol."},{"issue":"8","key":"19044_CR23","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s11136-016-1251-4","volume":"25","author":"J Wu","year":"2016","unstructured":"Wu J, Hu L, Zhang G, et al. Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory. Qual Life Res. 2016;25(8):2087\u2013100. https:\/\/doi.org\/10.1007\/s11136-016-1251-4.","journal-title":"Qual Life Res."},{"issue":"1","key":"19044_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12905-024-03068-1","volume":"24","author":"H Chen","year":"2024","unstructured":"Chen H, Zhou L, Fong D, et al. Quality of life and its related-influencing factors in patients with cervical cancer based on the scale QLICP-CE(V2.0). BMC Womens Health. 2024;24(1):277. https:\/\/doi.org\/10.1186\/s12905-024-03068-1.","journal-title":"BMC Womens Health."},{"issue":"5","key":"19044_CR25","first-page":"511","volume":"38","author":"C Wan","year":"2020","unstructured":"Wan C. Research status on the second version of the system of quality of life instruments for cancer patients QLICP V2.0. J Guangdong Med Univ. 2020;38(5):511\u20137.","journal-title":"J Guangdong Med Univ"},{"key":"19044_CR26","unstructured":"Yang Z. Development of the general module of the system of quality of life instruments for cancer patients V2.0 and estimation of its minimal clinically important difference. Southern Med Uni; 2015."},{"issue":"4","key":"19044_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/jep.13153","volume":"25","author":"YS Tsai","year":"2019","unstructured":"Tsai YS, Fang TP, Chi CC. A scale for measuring evidence-searching capability: a development and validation study. J Eval Clin Pract. 2019;25(4):676\u201381. https:\/\/doi.org\/10.1111\/jep.13153.","journal-title":"J Eval Clin Pract."},{"issue":"3","key":"19044_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1023\/B:QURE.0000021318.92272.2a","volume":"13","author":"P Schuck","year":"2004","unstructured":"Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used? Qual Life Res. 2004;13(3):571\u201386. https:\/\/doi.org\/10.1023\/B:QURE.0000021318.92272.2a.","journal-title":"Qual Life Res."},{"key":"19044_CR29","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2147\/IJGM.S447752","volume":"17","author":"L Qiao","year":"2024","unstructured":"Qiao L, Ding S, Ma W, et al. Development and validation of the Coronary Heart Disease Scale among the system of quality of life instruments for chronic diseases QLICD-CHD (V2.0) based on classical test theory and generalizability theory. Int J Gen Med. 2024;17:1975\u201389. https:\/\/doi.org\/10.2147\/IJGM.S447752.","journal-title":"Int J Gen Med."},{"key":"19044_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3758\/BF03203140","volume":"22","author":"RD Hays","year":"1990","unstructured":"Hays RD, Hayashi T. Beyond internal consistency reliability: rationale and use\u2019s guide for multi-trait analysis program on the microcomputer. Behav Res Methods Instrum Comput. 1990;22:167\u201375. https:\/\/doi.org\/10.3758\/BF03203140.","journal-title":"Behav Res Methods Instrum Comput."},{"issue":"1","key":"19044_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12876-020-01562-y","volume":"20","author":"C Wan","year":"2020","unstructured":"Wan C, Chen Y, Gao L, et al. Development and validation of the peptic ulcer scale under the system of quality of life instruments for chronic diseases based on classical test theory and generalizability theory. BMC Gastroenterol. 2020;20(1):422. https:\/\/doi.org\/10.1186\/s12876-020-01562-y.","journal-title":"BMC Gastroenterol."},{"issue":"4","key":"19044_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1023\/a:1023499322593","volume":"12","author":"CB Terwee","year":"2003","unstructured":"Terwee CB, Dekker FW, Wiersinga WM, et al. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res. 2003;12(4):349\u201362. https:\/\/doi.org\/10.1023\/a:1023499322593.","journal-title":"Qual Life Res."},{"issue":"5","key":"19044_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s0895-4356(99)00206-1","volume":"53","author":"JA Husted","year":"2000","unstructured":"Husted JA, Cook RJ, Farewell VT, et al. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000;53(5):459\u201368. https:\/\/doi.org\/10.1016\/s0895-4356(99)00206-1.","journal-title":"J Clin Epidemiol."},{"issue":"2","key":"19044_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.03.012.","journal-title":"J Clin Epidemiol."},{"issue":"3","key":"19044_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/07481756.2002.12069034","volume":"34","author":"RK Henson","year":"2001","unstructured":"Henson RK. Understanding internal consistency reliability estimates: a conceptual primer on coefficient alpha. Meas Eval Couns Dev. 2001;34(3):177\u201389.","journal-title":"Meas Eval Couns Dev."},{"issue":"5","key":"19044_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1023\/a:1015680029998","volume":"11","author":"J Thumboo","year":"2002","unstructured":"Thumboo J, Fong KY, Chan SP, et al. The equivalence of English and Chinese SF-36 versions in bilingual Singapore Chinese. Qual Life Res. 2002;11(5):495\u2013503. https:\/\/doi.org\/10.1023\/a:1015680029998.","journal-title":"Qual Life Res."},{"issue":"2","key":"19044_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/a:1022272620947","volume":"12","author":"S H\u00f6fer","year":"2003","unstructured":"H\u00f6fer S, Benzer W, Sch\u00fcssler G, et al. Health-related quality of life in patients with coronary artery disease treated for angina: validity and reliability of German translations of two specific questionnaires. Qual Life Res. 2003;12(2):199\u2013212. https:\/\/doi.org\/10.1023\/a:1022272620947.","journal-title":"Qual Life Res."},{"issue":"1","key":"19044_CR38","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12882-025-04585-3","volume":"26","author":"C Xu","year":"2025","unstructured":"Xu C, Li C, Hu L, et al. Development and validation of the renal cancer scale among the system of quality of life instruments for cancer patients QLICP-RE (V2.0): a multicenter longitudinal study. BMC Nephrol. 2025;26(1):648. https:\/\/doi.org\/10.1186\/s12882-025-04585-3.","journal-title":"BMC Nephrol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19044-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-19044-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19044-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:27:53Z","timestamp":1778869673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-19044-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19044"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-19044-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The study protocol and the informed consent form were approved by the IRB (institutional review board) of the affiliated hospital of Guangdong Medical University (PJ2012052, YJYS2019010). The respondents were voluntary and provided written consent for participation. The survey was in accordance with the ethical standards delineated in the 1964 Declaration of Helsinki and its subsequent amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}